From lab to market: MedTech lifecycle advisory, CDSCO regulatory strategy, and funding grant proposals for biotech/MedTech startups and academic labs
I'm Dr. Arijit Bhattacharjee — a biomedical scientist and MedTech strategist with a PhD and M.Tech in Biosciences & Bioengineering, currently leading medical device policy, indigenisation strategy, and public health research administration at the national level.
Over 6+ years, I've worked across the full innovation-to-impact chain: bench research, medical device innovation management, regulatory strategy, and government policy — shaping how technologies move from lab-stage research to national-scale adoption.
What I bring: A track record of translating deep scientific expertise into funded, de-risked, market-ready outcomes — having guided stakeholders to ₹20+ Crore in government funding and built the technical and regulatory credibility (4 granted patents, 15+ peer-reviewed publications) to back strategic decisions at every stage, from lab to policy table.
I work at the intersection of science, regulation, and strategy — helping startups, labs, and MedTech innovators navigate everything from concept validation and CDSCO approval to grant funding and market entry in India.
Work Terms
Hours of Operation
Flexible availability, with core working hours 7:00 PM – 10:00 PM IST on weekdays; extended availability on weekends by arrangement. Response to messages typically within 12–24 hours; urgent/active project queries may be addressed same-day within core hours. Calls/meetings outside core hours possible for international clients, by prior scheduling.
Payment Terms
Milestone-based payment for projects over 2 weeks; upfront/full payment for short-term or fixed-deliverable engagements
Guru.com's SafePay/escrow strongly preferred for all engagements
Hourly-rate work billed and invoiced weekly
Scope changes or revisions beyond the agreed deliverable will be quoted separately before proceeding
Preferred Communication
Guru.com messaging for initial scoping and official project record
Scheduled calls (Google Meet/Zoom) for detailed discussions, once engaged
Clear written brief/scope requested at project start to avoid ambiguity — happy to help structure this on a discovery call
Regular progress updates provided at agreed milestones (weekly, for longer engagements)
Other Terms
NDA available and welcomed for confidential or IP-sensitive projects — standard in regulatory and R&D consulting
Revisions: 1–2 rounds of revisions included per deliverable, as scoped upfront; additional rounds billed separately
Confidentiality maintained on all client data, unpublished research, and proprietary technical information
Long-term/retainer arrangements available for ongoing regulatory, grant, or advisory support — terms discussed case-by-case